CytoMed Therapeutics Limited (GDTC) Net income 2022–2025
CytoMed Therapeutics Limited (GDTC) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$3.1MFY2025 · since FY2022: -$2.3M → -$3.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.1M | -68.0% |
| FY2024 | -$1.8M | +41.2% |
| FY2023 | -$3.1M | -34.1% |
| FY2022 | -$2.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice